AnergiX: Phase I

Data from 31 patients showed that AnergiX.RA was safe and well tolerated at doses ranging from 0.5-150 ug/kg when given together with methotrexate, with no general immunosuppression or immunogenicity seen. A Paulus 20 response was seen in 50-75 percent of higher dose patients with antigen reactive T cells in their peripheral blood at baseline, compared to no patients in the placebo group. ...